Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04666337
Other study ID # 337/2/19
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 15, 2019
Est. completion date September 30, 2020

Study information

Verified date December 2020
Source Aswan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Supraclavicular brachial plexus approach is an alternative technique to general anesthesia resulting in a fast onset of a reliable blockage of the brachial plexus. The use of ultrasound for the performance of supraclavicular block has become the gold standard since it enables the clinician to deposit the local anesthetic close to the nerves in real-time that improves the success rate with a safety margin. Adjuvants are added to local anesthetic in Supraclavicular Brachial Plexus Blockade to improve the quality of nerve blocks and the duration of analgesia. It should be noted that no adjuvant has been approved by the Food and Drug Administration (FDA) for the prolongation of peripheral nerve blocks


Description:

There are multiple controversies among the previous studies for the use of different opioids as adjuvants for brachial plexus blockade to improve various block characteristics. Moreover, limited studies estimate the pons and cons of tramadol versus fentanyl as co-administrator to bupivacaine in Ultrasound-guided Supraclavicular Brachial Plexus Blockade. In our study, we aim to assess the utility of fentanyl versus tramadol as co-administrator to bupivacaine in ultrasound-guided supraclavicular brachial plexus blockade in upper limb surgeries in a prospective randomized controlled fashion. The primary outcome is to compare between the efficacy of tramadol versus fentanyl as adjuvants on the onset and duration of sensory and motor block and the secondary outcome is to compare between the efficacy of tramadol versus fentanyl as adjuvants on postoperative analgesia, time of the request to rescue analgesia, postoperative analgesic consumption, and complications. The patients were aged between 18 and 60, both gender, and the American Society of Anesthesiologists (ASA) physical status I/II. However, patients who had bleeding disorders got opioid analgesics or monoamine oxidase inhibitors before surgery, had a history of seizures, respiratory or cardiac diseases, local infections at the site where needle for the block is to be inserted, pregnant woman and in whom the block effect was partial and required supplementary anesthesia were excluded from the study. Patients were randomly allocated into three groups for ultrasound-guided supraclavicular brachial plexus block. Randomization was established using the computer-generated closed envelopes method. Group B (bupivacaine group): patients received 20 ml bupivacaine 0.5% plus 2 ml normal saline Group F (fentanyl group): patients received 20 ml bupivacaine 0.5% plus fentanyl (1µg/kg-2 ml) Group T (tramadol group): patients received 20 ml bupivacaine 0.5% plus tramadol (1mg/kg-2 ml)


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date September 30, 2020
Est. primary completion date August 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - American Society of Anesthesiologists (ASA) physical status I/II. scheduled for forearm or hand surgery Exclusion Criteria: - bleeding disorders - patients who got opioid analgesics or monoamine oxidase inhibitors before surgery, - history of seizures, respiratory or cardiac diseases - local infections at the site where the needle for the block is to be inserted - a pregnant woman - the block effect was partial and required supplementary anesthesia

Study Design


Intervention

Procedure:
ultrasound-guided supraclavicular brachial plexus blockade
Ultrasound-guided supraclavicular brachial plexus block was done using an ultrasound machine (Philips; Model: OTD020, AcBel Polytech Inc., Taiwan) with a 5-10 MHz linear probe. The brachial plexus and its relation to the surrounding structures were viewed while the patient was supine and the head turned 45° to the contralateral side. In the supraclavicular fossa, the probe was placed in the coronal plane to visualize the subclavian artery and the brachial plexus in a transverse sectional view. After skin sterilization and local anesthetic administration, an insulated needle was then introduced lateral to the ultrasound probe and parallel to the long axis of the probe. Once the needle penetrated the brachial plexus cluster, the local anesthetic mixture was injected incrementally after negative aspiration for blood or air just next to the artery, then the needle was repositioned to inject on the upper pole of the artery.

Locations

Country Name City State
Egypt Aswan University Hospital Aswan

Sponsors (1)

Lead Sponsor Collaborator
Aswan University Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Onset time of sensory block in minutes After the injection of the solution, every patient was checked for the onset of sensory blockade using goose soaked with iced normal saline by the following scale (three-point scale): Grade 0= perceived as normal sensation, Grade 1 = loss of cold sensation (analgesia), Grade 2= loss of sensation of touch (anesthesia). 40 minutes
Primary onset time of motor blockade in minutes using the modified Bromage scale (Three-point scale) the modified Bromage scale (Three-point scale): Grade 0: Normal motor function, Grade 1: Decreased motor strength with the ability to move the fingers only, Grade 2: Complete motor block with an inability to move the fingers. 40 minutes
Primary Duration of sensory block in hours It's the time from sensory block onset to the time of restoration of sensation at the surgical site 24 hours
Primary Duration of motor block in hours It's the time from motor block onset to the restoration of global mobility in the hand and the wrist. 24 hours
Secondary Visual analog scale (VAS): the VAS consisted of a straight, vertical 10-cm line; the bottom point represented "no pain" = (0 cm) and the top "the worst pain you ever have" = (10 cm). Patients were asked to rate their pain intensity at 1, 2, 4, 6, 12, 18, and 24 h after the block 24 hours
Secondary Postoperative first analgesic request time in hours was taken from the time of complete sensory block to the request to rescue analgesia when VAS > 4 cm. 24 hours
Secondary Rescue analgesia in the form of 0.05 mg/kg morphine sulfate intravenously was given when VAS = 4 cm 24 hours
Secondary Mean blood pressure in mmHg was measured before the block (0 min) and at 5, 10, 15, 30 min then 1, 2, 3, 6, 12,18and 24 h after the block 24 hours
Secondary heart rate in beats / minute was measured before the block (0 min) and at 5, 10, 15, 30 min then 1, 2, 3, 6, 12,18and 24 h after the block. 24 hours
Secondary peripheral oxygen saturation was measured before the block (0 min) and at 5, 10, 15, 30 min then 1, 2, 3, 6, 12,18and 24 h after the block. 24 hours
See also
  Status Clinical Trial Phase
Recruiting NCT00397995 - Undislocated Distal Both-Bone Forearm Fractures in Children N/A
Recruiting NCT00397852 - Dislocated Stable Distal Both-Bone Forearm Fractures in Children N/A
Recruiting NCT00398242 - Treatment of Stable Both-Bone Midshaft Forearm Fractures in Children N/A
Recruiting NCT00398268 - Dislocated Unstable Distal Both-Bone Forearm Fractures in Children N/A
Completed NCT04729868 - Ultrasound Guided Infraclavicular Brachial Plexus Block Using Levo-bupivacaine Alone or Combined With Dexmedetomidine for Hand and Forearm Surgeries N/A